Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
19.52
Price to sales ratio
2.95

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
877
RDY
Dr. Reddy's Laboratories Ltd
12.79 USD-1.01%-12.04%-4.48%-12.82%10.68 B USD
1003
ALKS
Alkermes plc - Ordinary Shares
50.97 USD-1.74%-7.04%+15.53%+70.24%8.50 B USD
1287
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
16.95 USD-1.34%-0.82%+5.15%+60.66%5.41 B USD
1356
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
40.26 USD+0.12%+1.44%+4.06%+19.82%4.91 B USD

Frequently asked questions about Lantheus Holdings, Inc. - Common Stock

What is the Lantheus Holdings, Inc. - Common Stock stock price today?

The current price of Lantheus Holdings, Inc. - Common Stock (LNTH) is 103.8. Over the past 24 hours, the stock has changed by -1.51%. Follow the LNTH chart for real-time price dynamics.

What is the stock ticker of Lantheus Holdings, Inc. - Common Stock?

Lantheus Holdings, Inc. - Common Stock trades under the ticker LNTH. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Lantheus Holdings, Inc. - Common Stock stock going up?

LNTH has changed by +2.31% over the last week, -0.93% over the last month, and +85.16% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Lantheus Holdings, Inc. - Common Stock net income for the last quarter?

Lantheus Holdings, Inc. - Common Stock reported net income of 118.42 M for the last quarter. The previous quarter showed 54.09 M, which means net income changed by +118.93%.

How many employees does Lantheus Holdings, Inc. - Common Stock have?

As of the latest available data, Lantheus Holdings, Inc. - Common Stock has 1 193 employees. Workforce size can provide additional context about the company's scale and operations.

What is Lantheus Holdings, Inc. - Common Stock EBITDA?

Lantheus Holdings, Inc. - Common Stock EBITDA is 233.83 M, and its EBITDA margin is 61.97%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Lantheus Holdings, Inc. - Common Stock stock?

You can buy Lantheus Holdings, Inc. - Common Stock (LNTH) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Lantheus Holdings, Inc. - Common Stock stock?

Investing in Lantheus Holdings, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LNTH chart and related analysis on metatrader.com as part of your research.

Lantheus Holdings, Inc. - Common Stock

Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers. Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden. Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade.

News